Hints and tips:
Related Special Reports
...Eli Lilly chief executive David Ricks described the acquisition as “unusual” on Tuesday and called for competition authorities to look into the deal....
...David Moore, vice-president for corporate development, added that the company would focus on acquisitions in diabetes and obesity, ideally in the early stage of development....
...One banker following the sector said Zealand’s amylin treatment was “one of the most advanced” in development and would make it an attractive acquisition target....
Deal with Atlas SP comes after private capital group acquired unit from Credit Suisse
Former US partners hire lawyers in fight for bigger share of the proceeds from New Mountain deal
...Chopra called for scrutiny of “past acquisitions” to avoid “catch and kill” deals that smother competitors....
Accounting firm recently agreed to sell a majority stake to New Mountain Capital
...New Mountain bought a controlling stake in Citrin Cooperman in 2022 and has helped fund an acquisition spree that has swelled the accounting firm’s annual revenues to an estimated $700mn....
...The acquisition also gives Novo Nordisk more expertise in RNA-based therapies, a growing field in pharmaceuticals....
...Novo Holdings owns 28 per cent of the shares in Novo Nordisk but has 77 per cent of the voting rights....
...Prior to the acquisitions last month, Novo Nordisk CEO Lars Fruergaard Jørgensen warned: “there’ll be a demand that outgrows what can be produced by us, and probably also competition”....
...Novo Nordisk said that the deal and its consequent acquisition of the sites would be subject to regulatory and shareholder approval....
...According to Dealogic, the outlay by Novo Nordisk and Eli Lilly compares to a total of $305mn that the entire pharmaceutical industry spent on acquisitions and partnerships in the field in the previous ten...
...Kutay and Novo Nordisk’s leadership “looked at each other and said ‘hold on a second’”, he said. Last week, Kutay led a $16.5bn acquisition of Catalent....
...Novo bulks up to boost sales of weight-loss drugs The Danish pharma giant Novo Nordisk has become Europe’s most valuable corporation by making drugs that help people lose weight....
...Darktrace’s board said: “The acquisition will provide Darktrace access to a strong financial partner in Thoma Bravo with deep sector and US markets expertise who can support Darktrace’s growth.”...
For regulators, the labour market is fair game in mergers and acquisitions
...Some of the biggest deals struck in the quarter included Capital One’s $35bn acquisition of Discover Financial, and chip design toolmaker Synopsys’s $35bn takeover of engineering software maker Ansys....
...Switzerland-based Mercuria, founded in 2004 by Marco Dunand and Daniel Jaeggi, was predominantly an oil trader but bolstered its power trading operations in 2014 through the acquisition of part of JPMorgan...
...a similar move by Meta earlier this year and underlines how US tech companies are now willing to give investors a greater share of their vast cash reserves, rather than hoarding them for investment or acquisitions...
Plus, the life of a Rothschild and the leveraged finance world sweats it out at JPMorgan’s confab in Miami
...This month Novo Nordisk signed deals worth up to $1bn with US biotechs, following several acquisitions last year....
...Need to know: business Novo Nordisk announced a €1bn deal for a German biotech developing therapies to treat heart disease, as the Danish group seeks to branch out from its blockbuster diabetes and weight...
...in February of major contract manufacturer Catalent by Novo Holdings, the parent company of Novo Nordisk....
Media company is already in exclusive talks with Skydance about a potential deal
International Edition